Radar > 229985

Galmed and OWL to collaborate in medicine manufacture for liver diseases

Galmed y OWL colaborarán en la elaboración de fármacos contra enfermedades hepáticas

Intel ID : 229985
Synopsis

Israel-based Galmed (NASDAQ: GLMD) and Spain-based OWL signed a collaboration agreement to develop drugs to fight liver diseases, as reported by OWL through a press release published on 29 September 2015.

The agreement is based on applying OWLiver, a system developed by OWL to diagnose non-alcoholic invasive liver disease, in a clinical trial on a drug to fight non-alcoholic steatohepatitis (NASH).

The agreement includes an acquisition right over a 19.9% stake in OWL in favor of Galmed, to be executed within a year and half since contract signature.
(content in spanish)

La empresa israelí Galmed (NASDAQ: GLMD) y la española OWL han firmado un acuerdo de colaboración para desarrollar fármacos contra enfermedades hepáticas, según ha señalado la propia OWL en una nota de prensa el 29 de septiembre de 2015.

El acuerdo se basa en la aplicación de OWLiver, un sistema desarrollado por la empresa española para el diagnóstico no invasivo de la enfermedad de hígado graso no alcohólico, en el ensayo clínico de un fármaco contra la esteatohepatitis no alcohólica (NASH, por sus siglas en inglés).

El acuerdo también implica la concesión a Galmed de una opción de compra del 19,9% del accionariado de OWL, a ejecutar en un plazo de un año y medio desde su firma.

Relevant Documents

Bidder

Israel
Spain

Intel ID 229985
Value ND
Native Currency Euro (EUR)
Financial Data - OWL
(31 Dec 2021)
Revenue: EUR 2,24m
EBITDA: EUR 0,57m
Net Debt: EUR 7,46m
People: 16
Date
Country
Region
Continent
Geography
Subsector (Old TTR Sectors)
Type
Intel Grade
Source
Tags

Bidder

Name
verified
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Country
Website
Description

Bidder

Name
verified
Subsector (Old TTR Sectors)
Technology and Telecoms / Biotechnology (Primary)
Primary Sector (TTRSC)
15.06.01 Colleges & Universities
15 Consumer Products & Services / 15.06 Education & Training Services

Country
Website
Description

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.